TIDMSKIN
RNS Number : 3971X
Integumen PLC
19 December 2019
AIM share code: SKIN
19 December 2019
Integumen PLC
("Integumen" or "Company")
Integumen signs 3-year revenue sharing Framework Agreement with
Parity Group plc
Further to the announcement of 13 November 2019, Rinocloud
Limited ("Rinocloud"), a subsidiary of Integumen has signed a
3-year Framework Agreement ("Agreement") with Parity Professionals
Limited ("Parity"), a subsidiary of Parity Group plc. The Agreement
is for the supply and roll-out of mobile enterprise resource, data
management and business tool software services to clients from the
National Health Service ("NHS"), Public Sector, Utilities, Housing
Associations and Private Institutional companies.
Gerard Brandon, CEO of Integumen, & Director of Rinocloud,
comments:
"Following on from the Heads of Terms signed with Parity
announced five weeks ago, the Parity Team offers Rinocloud a vendor
approved, ready-made sales, marketing and distribution channel into
the ideal clients for its mobile enterprise resource and data
management software services. The teams have jointly identified a
number of clients across the Parity client portfolio who would
benefit from working with Rinocloud and we will initiate
consultations with them early in 2020."
Matthew Bayfield, CEO of Parity Group plc, & Director of
Parity Professionals Ltd., comments:
"Our Agreement with Rinocloud is a complementary combination of
Parity Professional people and Rinocloud software services who are
set to define, develop and deploy value-added mobile enterprise
resource and data management solutions across our public sector and
private institutional clients. By increasing value for our clients,
we increase our revenue per client, increase client contract terms,
generating a higher margin and profitability."
Combined benefits:
-- Recurring shared revenue streams for both Parity and Integumen in 2020
-- Value-added proposition in demand from Parity clients with c. 3 to 5-year annual contracts
-- Immediate access to 150 public and private institutional clients
-- Trusted approved vendor for Government and private sectors for over 45 years
-- 1,000+ data experts and 100+ enterprise sales and office professionals
-- Existing cross-over access to educational institutional research facilities
-- Access to multiple industry, public and private sector distribution routes to market
-- Well defined roadmap to next level business growth for both Parity and Integumen
Contacts
+44 (0) 7340 055
Integumen plc Gerard Brandon, CEO 648
SPARK Advisory Partners Limited Neil Baldwin/Andrew +44 (0) 113 370
(Nominated Adviser) Emmott 8974
---------------------------- -----------------
Turner Pope Investments (TPI) +44 (0) 20 3657
Limited (Broker) Andy Thacker/Zoe Alexander 0050
---------------------------- -----------------
About Integumen: www.integumen.com
Integumen is a vertically integrated product and services
company for skin related diseases, treatments and therapies with
four business units:
-- Labskin AI's technology platform incorporates artificial
intelligence within clinical research for medical device,
pharmaceuticals, cosmeceuticals and related life science test
services. Labskin allows skincare, healthcare, pharmaceutical
manufacturers and cosmetic companies to test their products on
human-like skin in a real-world environment with full access to
multiple state-of-the-art partner technologies.
-- Rinodrive is a data aggregation, refining and AI analysis
open-source eco-system designed to provide third-party service
providers the ability to offer their clients valuable insights that
support clinical, operational and financial decisions in healthcare
services, third-level education, government departments and the
financial sector.
-- Wound pHase is developing skin and wound care products using
its proprietary wound dressing technology. Working in collaboration
with CBD providers creating a CBD infused diabetic wound care
product range.
-- Stoer-for-men skin products e-commerce division offers a
range of skincare products derived from 5 natural super-ingredient
plant extracts specifically for men to reduce the signs of ageing
and is also used as a control for client testing within Labskin
laboratories.
About Parity Group plc: www.parity.net
Parity helps organisations find the right people, skills and
data to support data-led business decisions. Providing advice on
data and with access to qualified personnel with skills offered,
either as a managed service, through resourcing in the contract or
permanent market or as part of a learning and development
programme.
Income derives from a mix of long-term contracts with public and
private sector organisations as well as expanded projects with
existing clients as a result of strong relationships and a track
record of high client satisfaction. Key highlights comprising
of:
-- Over 45 years of expertise in public and private recruitment and service contract sector
-- More than 100 employees across the UK
-- Client numbers exceed 150 in both UK and Ireland
-- Associate numbers supporting client services exceeds 1,000
Rinocloud: www.rinodrive.com
A fully integrated set of software tools that can ingest data,
in any volume, from any source in any format, interact with it,
learn from it and enrich it to unlock insights and discoveries.
This data management solution was developed by scientists and
engineers with experience in software, sensors, AI, optofluidic
research, fintech, green-tech, travel and healthcare.
It was designed to allow interaction, in a cyber-secure
environment, with commercially sensitive data, and to share
insights across multi-disciplinary teams, generating different data
formats, from multiple sources, located in different countries.
RinoDrive delivers big data, AI functionality and world class
infrastructure to large companies with big data problems. These
include financial services, education and life science companies.
Most recently completing the automation of laboratories and
application of AI to unearth more knowledge about the skin
microbiome. This led to the acquisition in May 2019 by Integumen,
to secure access to, and the exploitation of data from some of the
largest cosmetic, pharmaceutical and medical companies in the
world.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFFWFWAFUSELE
(END) Dow Jones Newswires
December 19, 2019 02:00 ET (07:00 GMT)
Grafico Azioni Integumen (LSE:SKIN)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Integumen (LSE:SKIN)
Storico
Da Mar 2023 a Mar 2024